Professional Overview
Lisa Pan is a multifaceted professional currently serving as the Founder, CEO/CMO, leveraging her expertise in psychiatry, human genetics, and molecular sciences to drive innovation. Her key areas of expertise include molecular genetics, psychiatry, and mental health initiatives, with a focus on advancing healthcare through cutting-edge technologies and community engagement.
Experience Summary
Current Role
As the Founder, CEO/CMO at New Hope Molecular, Lisa Pan is responsible for overseeing the strategic direction, research and development, and clinical applications of molecular sciences in psychiatry. Her key responsibilities include leading a team of researchers and clinicians, developing novel therapeutic approaches, and fostering partnerships with academic and industry stakeholders. Notable achievements in this role include the establishment of a multidisciplinary research program and the development of innovative, genetics-based treatments for psychiatric disorders.
Career Progression
Lisa Pan's career trajectory reflects a steady progression from academia to entrepreneurship, with a consistent focus on psychiatry, human genetics, and translational research. Previously, as an Assistant Professor of Psychiatry, Human Genetics, and Clinical and Translational Science at the University of Pittsburgh School of Medicine, she conducted research, taught, and practiced clinically, laying the groundwork for her current endeavors.
Academic Background
Although specific details on Lisa Pan's highest level of education are not provided, her professional background indicates a strong foundation in medicine, particularly psychiatry, and human genetics. Her academic achievements are reflected in her appointments as an Adjunct Professor and her research contributions.
Areas of Expertise
Lisa Pan's expertise spans:
- Industry-specific skills: Molecular genetics, psychiatric treatment, and mental health advocacy.
- Technical competencies: Research and development, clinical practice, and team leadership.
- Leadership and management capabilities: Strategic planning, partnership development, and team management.
Professional Impact
Notable initiatives include the founding of the Panomics Mental Health Initiative, a 501c3 organization, which underscores her commitment to community mental health and the application of genetic insights to improve psychiatric care. Her measurable achievements include the establishment of a successful psychiatric practice and her contributions to the field through research and education.
Conclusion
Lisa Pan's professional trajectory is marked by a dedication to advancing psychiatric care through genetic research and community engagement. Currently, her focus is on leading New Hope Molecular and the Panomics Mental Health Initiative, capitalizing on her unique blend of clinical, academic, and entrepreneurial expertise. Her value proposition lies in her ability to bridge the gap between genetic research, psychiatric practice, and community mental health initiatives, driving innovation and improvement in patient care.
